EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
December 06, 2023 16:30 ET
|
EDAP TMS S.A.
LYON, France, December 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Lance Willsey, M.S.,...
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
November 30, 2023 08:00 ET
|
EDAP TMS S.A.
LYON, France, November 30, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that is has received the Industry Category Award from the...
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
November 20, 2023 08:00 ET
|
EDAP TMS S.A.
LYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is...
EDAP Announces Third Quarter 2023 Financial Results
November 09, 2023 06:00 ET
|
EDAP TMS S.A.
- Strong Q3 2023 U.S. Focal One® HIFU procedure growth of +150% year-over-year - - Record nine months HIFU revenues reflecting growing demand - - Two additional Focal One systems...
EDAP to Present at the Jefferies London Healthcare Conference
November 06, 2023 08:00 ET
|
EDAP TMS S.A.
LYON, France, November 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is...
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
October 26, 2023 08:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 9th at 8:30am EDT LYON, France, October 26, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference
September 06, 2023 08:00 ET
|
EDAP TMS S.A.
LYON, France, September 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is...
EDAP Announces Second Quarter 2023 Financial Results
August 24, 2023 06:30 ET
|
EDAP TMS S.A.
- Record second quarter and first half revenues of EUR 14.3 million (USD 15.5 million) and EUR 29.1 million (USD 31.5 million), respectively - - Total HIFU Q2 2023 year-over-year revenue growth...
EDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023
August 10, 2023 08:00 ET
|
EDAP TMS S.A.
- Company to host conference call and webcast on Thursday, August 24th at 8:30 am EDT - LYON, France, August 10, 2023 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based...
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
July 26, 2023 08:00 ET
|
EDAP TMS S.A.
LYON, France, July 26, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it has received reimbursement approval in...